Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial (Q44663294)
Jump to navigation
Jump to search
scientific article published on 25 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial |
scientific article published on 25 June 2012 |
Statements
1 reference
Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial (English)
1 reference
M Szulinska
1 reference
P Bogdanski
1 reference
D Pupek-Musialik
1 reference
A Jablecka
1 reference
H Witmanowski
1 reference
25 June 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference